Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

Inclusion Criteria: * Diagnosis of macular edema due to branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) * Central subfield thickness \> 300 μm * BCVA of ≥ 24 and ≤ 68 letters * Males and non-pregnant females 18 years and over Exclusion Criteria: * Macular edema secondary to any condition other than RVO * Presence of foveal atrophy, dense pigmentary changes or dense subfoveal exudates in the study eye * Cystic intraretinal hemorrhage involving the fovea in the study eye that is responsible for vision loss * Glaucoma or ocular hypertension (IOP \> 21 mmHg or concurrent therapy at screening with IOP-lowering agents) * Any prior treatment with intravitreal, subtenon, or periocular steroid or anti-VEGF therapy since the diagnosis of RVO in the study eye * Any change in systemic steroid therapy within 3 months of screening * History of vitrectomy in the study eye